Opinion
MISC. CASE NO. 6:17-mc-00080
05-08-2017
PHILLIP GETZ AS SPECIAL ADMINISTRATOR OF THE ESTATE OF NORMAN GETZ v. TAKEDA PHARMACEUTICALS U.S.A, INC. AND TAKEDA PHARMACEUTICAL COMPANY LIMITED
JUDGE DOHERTY
REPORT AND RECOMMENDATIONS ON UNOPPOSED MOTION FOR SETTLEMENT AS TO CLAIMS OF DECEDENT , NORMAN GETZ
This Court, having reviewed Plaintiffs' Unopposed Motion to Approve Settlement as to Claims of Phillip Getz, as Special Administrator and Derivative Claimant; and Esther Getz as Derivative Claimant and Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. (collectively "Takeda"), the parties having received due notice of and having had the opportunity to be heard, and this Court having considered all submissions made, I recommend to the Court that the Motion be
GRANTED and
The settlement by and between Plaintiffs, Phillip Getz, as Special Administrator and Derivative Claimant; and Esther Getz as Derivative Claimant individually and as legal heirs to the Estate of Norman Getz, deceased, and Takeda, as notice to the Court on May 4, 2017 be
APPROVED.
The Court has jurisdiction of this matter by virtue of the Plaintiffs participating in the Actos MDL Master Settlement Agreement.
ANY PARTY OBJECTING TO THIS RECOMMENDATION SHALL SUBMIT OBJECTIONS, IN WRITING, DIRECTLY TO JUDGE DOHERTY'S CHAMBERS - AND SHALL NOT FILE THE OBJECTION INTO THE RECORD - NO LATER THAN TEN (10) DAYS AFTER ENTRY OF THIS RECOMMENDATION.
If there is no objection within ten (10) days of the entry of this Recommendation, the Recommendation will become an Order.
This is DONE AND SIGNED in Lafayette, Louisiana, this 8th day of May 2017.
/s/_________
HONORABLE PATRICK J. HANNA
UNITED STATES MAGISTRATE JUDGE